The global aerosol delivery devices market reached a value of US$ 41.45 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 60.14 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027.
Aerosol delivery devices are handheld, portable drug delivery devices used in treating respiratory disorders, such as asthma, obstructive lung diseases, pulmonary infections and arterial hypertension, and cystic fibrosis. They aid in lessening dosage requirements, reducing systemic adverse effects, and improving the ability of patients to self-administer medication. At present, due to the advent of novel macromolecular medications, smart aerosol delivery devices are finding extensive application in non-respiratory conditions, such as analgesia, diabetes, and Parkinson’s disease.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global Aerosol Delivery Devices Market Trends:
The rising air pollution levels globally due to rapid urbanization and industrialization are increasing the risk of developing respiratory disorders, such as chronic obstructive pulmonary disease (COPD). This represents one of the key factors driving the market. Besides this, the sudden outbreak of coronavirus disease (COVID-19) that leads to acute respiratory infections among patients is positively influencing the market. Moreover, the leading market players are developing novel aerosol delivery devices that help treat lung infection and chronic inflammation and enhance airway clearance in patients with cystic fibrosis. This, in confluence with the rising demand for personalized drug therapy and the escalating use of online channels for buying medical supplies, is anticipated to strengthen the market growth.
Request Free Sample Report: https://www.imarcgroup.com/aerosol-delivery-devices-market/requestsample
Global Aerosol Delivery Devices Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.
The report has segmented the market on the basis on region, product, application, distribution channel.
Breakup by Product:
- Dry Powder Inhalers
- Single Dose Inhalers
- Multi Dose Inhalers
- Metered Dose Inhalers
- Conventional Pressurized Inhalers
- Soft Mist Inhalers
- Nebulizers
- Jet Nebulizers
- Ultrasonic Wave Nebulizers
- Vibrating Mesh Nebulizers
Breakup by Application:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
- Non-Respiratory Diseases
- Diabetes
- Analgesia
- Parkinson’s Disease
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Stores
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://bit.ly/3sNlMdI
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800